Home
overview

SMi is delighted to announce its inaugural Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 22nd - 23rd May 2017, and featuring two post-conference workshops on the 24th May!

 

The global market for Highly Potent Active Pharmaceutical Ingredients is currently on a growth fast track, largely driven by its major use in oncology for cancer treatment and more often in the form of ADCs. Over a quarter of drugs worldwide now contain HPAPIs, as they have proven to be more effective than other APIs.
However, working with APIs high in potency and cytotoxicity comes with many regulations and requirements, and presents pharmaceutical companies with challenges such as handling, containment, cost and security questions.

 

The inaugural Highly Potent Active Pharmaceutical Ingredients conference features key speakers of the industry presenting challenges, issues, innovation and new developments in various areas of HPAPI production, development and manufacturing.
Hear about new innovative containment risk assessment tools and containment strategies when handling HPAPI products. Guidance for the evaluation and management of cross-contamination will be addressed, as well as newest control strategies and solutions.
Pharmaceutical companies will be presenting their approaches to scale-up processes and will be discussing manufacturing facility designs and requirements, also introducing flexible facilities. Learn more about CMO selection strategies and how to improve information and technology transfer.

 

This conference will cover many important and in-demand aspects of the HPAPI industry, creating a networking platform for industry professionals and key players to share their knowledge and find innovative new solutions.

  • Learn how to reduce HPAPI manufacturing costs and get the best value for your money without cutting back on the importance of safety and containment procedures.

 

  • Network with industry fellows and hear about new developments, innovation and challenges in areas such as cross-contamination, manufacturing efficiency, safety practices, outsourcing strategies, compound development and manufacturing, etc.

 

  • Hear about the HPAPI market development, reasons why it’s growing so rapidly and how to benefit from this, as well as why the HPAPI demand is still higher than the supply despite there being various suppliers involved in the industry.

 

  • Experience an information-packed learning environment, designed to provide you with the best insight into new innovation in the HPAPI sector, leaving you well prepared for the challenges you’re currently facing.

Previous attendees included:

 

Abzena; ADC Biotechnology; Antikor Biopharma Ltd; Antikor Biopharma Ltd.; AS-Tec Chemicals Ltd; AstraZeneca; Cancer Research Technology Ltd; Cancer Research UK; CARBOGEN AMCIS AG; Cfm Oskar Tropitzsch e.K.; Crescendo Biologics Ltd; Endocyte, Inc.; Heraeus Precious Metals GmbH & Co. KG; Immunogen; King's College London; Lonza Ag; Medimmune; MedImmune Inc; Menarini Ricerche; Merrimack Pharmaceuticals Inc; MRC Technology; NBE Therapeutics; Novartis Biologics; Novasep; Oncotec Pharma Produktion GmbH; Pfizer; Piramal Pharma Solutions; Roche Pharmaceuticals; Schering; Sigma-Tau Industrie Farmaceutiche Rimile SpA; SKAN AG; Syndivia; Takeda Pharmaceuticals; The University of Bath; Thomson Reuters; UCL; University College London; University Of Bath;

Conference programme

8:30 Registration & Coffee

9:00 Chairperson's Opening Remarks

Ildiko Ziegler

Ildiko Ziegler, Distinguished Validation Expert, Gedeon Richter Plc.
View Bio

9:10 Containment strategies for high potency APIs

Jason Hamm

Jason Hamm, Director - Chemical Development Operations, Bristol-Myers Squibb
View Bio

  • Engineering controls utilized in API plants for HPAPI’s
  • Effectively scaling up potent APIs from clinical to manufacturing scale
  • Criteria for selecting an external vendor for the manufacture of HPAPI’s
  • Development of robust process utilizing plant data systems
  • 9:50 ISPE Containment Manual

    Richard Denk

    Richard Denk, Head Sales Containment, SKAN AG
    View Bio

  • Containment from the PDE/OEL to Life Cycle
  • Full overview on Containment
  • Important to consider to design a Containment Facility
  •  

    10:30 Morning Coffee

    11:00 CMC Development Projects – Starting It Right Process Feasibility or Process Technology Transfer

    Eberhard Ramisch

    Eberhard Ramisch, Global Head Projectmanagement Pharmaceutical Ingredients, Heraeus GmbH & Co. KG
    View Bio

  • Outsourcing of novel complex cytotoxic components is challenging
  • Misunderstandings and high risk approaches can lead to delays and substantial cost increase
  • Smart Case studies to avoid obstacles and early pitfalls
  • 11:40 Cross contamination risk assessment in multi-product facilities: case studies on steroid hormones and cytotoxic products

    Ildiko Ziegler

    Ildiko Ziegler, Distinguished Validation Expert, Gedeon Richter Plc.
    View Bio

  • Toxicological concerns in „cross contamination” guidelines
  • Complexity of cross contamination risk and technical measures at production areas
  • Case study 1: steroid hormonal API production
  • Case study 2: manufacturing parenteral cytotoxic products
  • 12:20 Networking Lunch

    13:30 Assessing Highly Hazardous Drugs within Quality Risk Management Programs

    Robert Sussman

    Robert Sussman, Principal Toxicologist and Managing Principal, Eastern Operations, SafeBridge Consultants LLC
    View Bio

  • “Categories of concern” (cytotoxics, hormones, steroids) are often referred to, but rarely defined for APIs requiring segregation or dedication in manufacturing
  • Characteristics of these categories are discussed to identify and prioritize compounds requiring special attention
  • Controlling airborne concentrations and the contamination of product contact surfaces to values derived from quantitative risk assessments is more appropriate, regardless of specific categorical designations
  • Industry movement is toward establishing compound-specific health-based limits and performing risk assessments to determine whether segregation and/or dedication may be required
  • 14:10 Scale-up of HPAPIs and their Unique Challenges

    Jack Brown

    Jack Brown, Senior Principal Scientist, Boehringer Ingelheim Pharmaceuticals, Inc.
    View Bio

  • Challenges with HPAPIs are very unique, in that there is typically limited data on.
  • This would include process safety data (calorimetry, toxicological data for intermediates)
  • Will discuss approaches to both and upside and down sides for each)
  • There is typically limited process data as well. How do you understand the processes and their characteristics?
  • 14:50 Afternoon Tea

    15:20 SHE criteria for the selection of potent compound contract manufacturers

    Andreas Flueckiger

    Andreas Flueckiger, Chief Occupational Health Officer, Roche
    View Bio

  • General SHE aspects: no undue risk for the project
  • Compliance with worker health regulations in an environment where no-one complies
  • Basic understanding of occupational health risk assessments: hazard and exposure
  • Documented containment capabilities: having the data and being able to explain them
  • Project-specific tech transfer: competent and responsive partners wanted
  • 16:00 Working with CMOs to manufacture HPAPI and its Intermediates

    Angela Zhou

    Angela Zhou, Senior Sourcing Manager, Genentech
    View Bio

  • Today’s landscape on the awareness of HPAPI and its containment requirement
  • Containment levels at CMOs all over the world
  • How to work with CMOs on producing HPAPI and its intermediates
  • Progress made by Asian CMOs
  • 16:40 Containment Risk Assessment of HP Drug Substance through FMECA

    Fabio  Zenobi

    Fabio Zenobi, EHS Director, BSP Pharmaceuticals
    View Bio

  • Introduction of a Drug Product
  • Impact evaluation
  • Operating Control
  • Product Decommissioning
  • 17:20 Chairperson’s Closing Remarks and Close of Day One

    Ildiko Ziegler

    Ildiko Ziegler, Distinguished Validation Expert, Gedeon Richter Plc.
    View Bio

    8:30 Registration & Coffee

    9:00 Chairperson's Opening Remarks

    Ildiko Ziegler

    Ildiko Ziegler, Distinguished Validation Expert, Gedeon Richter Plc.
    View Bio

    9:10 Navigating the EU regulatory landscape with the Small Molecule Drug Conjugate (SMDC) Vintafolide

    Michael Groaning

    Michael Groaning, Director, Strategic Development, Endocyte
    View Bio

  • Novel approach to containment of vintafolide during the drug substance isolation process
  • CMC Regulatory interactions with the European Health Authorities during a centralized Marketing Authorization Application review process
  • Guided tour of the convoluted landscape traveled to reach a positive CHMP opinion
  • 9:50 EMA Guideline on setting health based exposure limits and its application for highly potent APIs in early development

    Claudia Sehner

    Claudia Sehner, Principal Scientist, Occupational Toxicology, Boehringer Ingelheim
    View Bio

  • EMA Guideline on setting health based exposure limits and it’s draft Q&A on implementation
  • Approaches for setting PDEs/TTCs for APIs in early development
  • Consideration on mode of action and it’s potential for adverse effects (e.g. developmental toxicity)
  • 10:30 Morning Coffee

    11:00 Performance to Plan in the API industry

    Jhon  Escobar

    Jhon Escobar, Operations / Supply Chain Manager, Teva API
    View Bio

  • Operations & Supply Chain as intimate friends
  • Planning process & S&OP
  • Performance to plan
  • Relevant KPI’s in the operation for business perspective
  • 11:40 Avibactam; a novel ß-lactamase inhibitor extending the utility of ß-lactam antibiotics in life threatening infections

    Gwydion  Churchill

    Gwydion Churchill, Associate Director of Chemistry, Antibiotics Business Unit, AstraZeneca
    View Bio

  • The urgent need for new antibiotics
  • The challenges faced with the development and manufacture of new antibiotics
  • The discovery and mechanism of action of Avibactam
  • Future directions for the field
  • 12:20 Networking Lunch

    13:30 Case Study: Process Equipment integration into HPAPI’s Containment systems – from R&D to Production Scale

    Stefano Butti

    Stefano Butti, Head of Sales Group, F.P.S. Food and Pharma Systems Srl
    View Bio

  • Proper Containment strategy selection to meet product and process specification
  • Project Development critical phases
  • Fully integrated R&D, Pilot and Production Unit down to nanograms Containment Level
  • Conclusions and new challenges
  • 14:10 Implementation of the ICH M7 Guideline at Roche: Systematic Evaluation of in silico systems and workflow

    Alessandro  Brigo

    Alessandro Brigo, Principal Scientist – Toxicology Project Leader, Roche
    View Bio

  • Short overview of the ICH M7 Guideline in the context of the in silico assessment
  • In silico prediction systems
  • Comparative prediction models validation
  • Process and Workflow
  • 14:50 Afternoon Tea

    15:20 How to deal with HPAPI’s chemical manufacturing

    Aurore Perzyna

    Aurore Perzyna, Head, Production Plant, Oril Industries
    View Bio

  • Risk assessment with our methodology of safety requirement
  • How to decrease the risk to handle HPAPI
  • Our choice for containment equipment and technology
  • 16:00 HPAPI Manufacturing: A Holistic, Practical Approach

    Gregory Sowell

    Gregory Sowell, Principal Scientific Manager, Small Molecule Process Chemistry, Genentech
    View Bio

  • Evaluation of the entire process
  • Internal vs. CMO manufacturing and oversight
  • Engineering controls and training
  • 16:40 Chairperson’s Closing Remarks and Close of Day Two

    Ildiko Ziegler

    Ildiko Ziegler, Distinguished Validation Expert, Gedeon Richter Plc.
    View Bio

    +

    FEATURED SPEAKERS

    Andreas Flueckiger

    Andreas Flueckiger

    Chief Occupational Health Officer, Roche
    Gwydion  Churchill

    Gwydion Churchill

    Associate Director of Chemistry, Antibiotics Business Unit, AstraZeneca
    Ildiko Ziegler

    Ildiko Ziegler

    Distinguished Validation Expert, Gedeon Richter Plc.
    Jack Brown

    Jack Brown

    Senior Principal Scientist, Boehringer Ingelheim Pharmaceuticals, Inc.
    Jason Hamm

    Jason Hamm

    Director - Chemical Development Operations, Bristol-Myers Squibb
    Michael Groaning

    Michael Groaning

    Director, Strategic Development, Endocyte

    Alessandro Brigo

    Principal Scientist – Toxicology Project Leader, Roche
    Alessandro  Brigo

    Alessandro Brigo is a Principal Scientist and Toxicology Project Leader in the Pharmaceutical Sciences organization at Roche Innovation Center Basel, Switzerland. In this role Alessandro leads drug discovery and development programs from a toxicology perspective to deliver scientific support through all development phases and for marketed products.
    Alessandro has also been working in the field of Computational Toxicology since 2006, in particular on the assessment of potential genotoxic impurities in active pharmaceutical ingredients at development and marketing stages.
    Alessandro is a pharmacist by training with a PhD in Pharmaceutical Sciences and a board certification in toxicology (DABT).

    Andreas Flueckiger

    Chief Occupational Health Officer, Roche
    Andreas Flueckiger

    Andreas Flueckiger, MD, is holds certifications in General Internal and Occupational Medicine.
    He works for F. Hoffmann-La Roche Ltd, in Basel (Switzerland) in the role of Chief Occupational Health Officer. He is in charge of the Roche Group’s occupational health and hazard assessment programs. He is engaged in standard-setting, auditing and teaching activities and is a member or honorary member in several professional organisations.

    In his functions, Dr. Andreas Flueckiger has gained over 30 years of experience in occupational toxicology, in particular hazard assessment and limit value setting for occupational health and GMP. As by law, workers need to be protected by technical solutions, Dr. Flueckiger has broad experience in containment technology and exposure control in the pharmaceutical industry.

    Angela Zhou

    Senior Sourcing Manager, Genentech
    Angela Zhou

    Ms. Angela Zhou received her MS in organic chemistry from University of Wisconsin - Madison and joined Pfizer in 1992. She started her career as a medicinal chemist, and designed and synthesized Pfizer’s Ibrance, a multimillion dollar drug towards breast cancer. She has 5 patents, 16 publications and 19 presentations.
    In 2002 she became a sourcing manager and provided outsourcing support to all Pfizer’s discovery sites. During this period time she worked with a lot of CROs and managed multi million dollars.
    In 2009 Angela joined Genentech as a sourcing manager to support Genentech’s small molecule development activities. She has significantly expanded their CMO portfolio and manages CMOs worldwide.

    Aurore Perzyna

    Head, Production Plant, Oril Industries
    Aurore Perzyna

    Formation: Engineer and PhD in Organic Chemistry
    Experience: for 12 years in Oril Industrie (Servier's group) mainly in R&D: Route scouting, development of industrial route, manufacturing of clinical batches of API under development.
    Now I’m head at the production plant.
    HPAPI: interested by this topic for 8 years: knowledge about containment equipment and technology, manufacturing HPAPI batches (GMP or not), worker’s training, SOP writing…

    Claudia Sehner

    Principal Scientist, Occupational Toxicology, Boehringer Ingelheim
    Claudia Sehner

    Dr. Claudia Sehner is Principal Scientist at Boehringer Ingelheim Pharma GmbH & Co. KG in Biberach (Germany). She is responsible for Occupational Exposure Limits (OELs) and Permitted Daily Exposure Limits (PDEs) setting and the organization of the respective committee at Boehringer Ingelheim. Besides >12 years of experience in toxicological risk assessment/limit setting, Claudia Sehner has expertise as project toxicologist and in the fields of in vitro toxicology and toxicogenomics. Claudia Sehner graduated with a Diploma in Chemistry from the Johannes Gutenberg University, Mainz, earned her doctorate at the Institute of Toxicology (Mainz), and is a board certified toxicologist (DGPT).

    Dean Calhoun

    President / CEO, Affygility Solutions
    Dean Calhoun

    Workshop Leader A

    Dean Calhoun is an American Board of Industrial Hygiene Certified Industrial Hygienist (CIH). He has been an environmental health and safety professional for over 30 years.
    Prior to starting Affygility Solutions, Dean was the Associate Director of Environmental Health and Safety for Gilead Sciences, Inc., a biopharmaceutical company focused on developing pharmaceuticals for infectious, viral, and oncology applications. His experiences including development and implementation of global EHS guidelines, implementation and coordination of an executive management EHS Steering Committee, establishment of occupational exposure limits for pharmaceutical active ingredients, industrial hygiene program management, and EH&S auditing of research, manufacturing and contract manufacturing facilities.
    Dean has spoken for a number of professional organizations including the U.S. Environment Protection Agency, the Colorado Safety Association, the Bay Area Environmental Safety Group, the National Association for Environmental Management, the National Safety Council, the Occupational Safety and Health Administration, and the American Industrial Hygiene Association.

    Dean has also presented at the HPAPI 2012 and 2013 conferences in Philadelphia, PA, and at the High Potent Drugs 2013 conference in Mumbai, India. Dean graduated with a B.Sc. degree in Engineering from the University of Wyoming and has dual master degrees in Environmental Policy and Management, and Technology Management from the University of Denver. He is a member of AIHA, ASSE, and NAEM.

    Eberhard Ramisch

    Global Head Projectmanagement Pharmaceutical Ingredients, Heraeus GmbH & Co. KG
    Eberhard Ramisch
    • Pharmacist by training / Gradate Degree from University of Mainz
    • 20+ years in various strategic and operational functions in the pharmaceutical Industry mainly in Oncology
    • Since 2012 with HERAEUS leading the Global Project Management Pharmaceutial Ingredients, which is mainly leading CDMO projects as well as strategic initiatives to broaden the service offerings of the Business Unit

    Fabio Zenobi

    EHS Director, BSP Pharmaceuticals
    Fabio  Zenobi

    Fabio is responsible of Environment, Health and Safety at BSP Pharmaceuticals S.p.A., Latina Italy, a Contract Development and Manufacturing Organization focused on anticancer product, small molecules and ADC compounds. He is a Pharmaceutical Chemist and has over 20 years of experience in pharmaceutical industries as Serono, Bristol-Myers Squibb and Intervet, in Manufacturing, Quality Assurance, Technical Operations and EHS.

    Gregory Sowell

    Principal Scientific Manager, Small Molecule Process Chemistry, Genentech
    Gregory Sowell

    Dr. Sowell has over 25 years of pharmaceutical experience in small molecule process development and manufacturing. He has been at Genentech for the past 10 years where he leads a team of process chemists as well as heads the small molecule GMP API manufacturing facility. He has also served at the Technical Development Team leader for numerous development projects including that for Cobimetinib. In these roles, Dr. Sowell has developed experience and appreciation for leveraging a risk based, practical approach to manufacturing APIs, including highly potent small molecules, for clinical trials with an eye on worker protection, process safety and regulatory compliance while balancing corporate goals for timelines and cost.

    Gwydion Churchill

    Associate Director of Chemistry, Antibiotics Business Unit, AstraZeneca
    Gwydion  Churchill

    Gwydion studied organic chemistry at Swansea University and then for a PhD at Nottingham university. He then moved to Oxford university to undertake post-doctoral studies. He has worked at AstraZeneca for 10 years in a number of roles and is currently Associate Director for Chemistry in the Antibiotics Business Unit.

    Ildiko Ziegler

    Distinguished Validation Expert, Gedeon Richter Plc.
    Ildiko Ziegler

    Dr. Ildiko Ziegler has been a professional at Gedeon Richter for 13 years and leading different projects in her field for 3 years. She has been a distinguished validation expert since Jan 2014, specialised for cleaning validation and quality risk assessment in pharma industry. Ildiko obtained M.Sc. in chemical engineering at the Budapest University of Technology and Economics (BUTE) in 1996. She recieved licentiate degree at the Luleå University of Technology (Sweden) in 2000. She defended Ph. D. at the BUTE in 2000 and obtained the Géza Schay Award for the achievments in the field of physical and theoretical chemistry.

    Jack Brown

    Senior Principal Scientist, Boehringer Ingelheim Pharmaceuticals, Inc.
    Jack Brown

    Dr. Jack Brown is a Senior Principle Scientist at Boehringer Ingelheim Pharmaceuticals with over 25 years of experience in the pharmaceutical industry. Prior to the current position, held positions with Boehringer Ingelheim Chemicals (as Associate Director of Process Chemistry and prior to that was the Director of Technical Operations), Roche Colorado Corporation (Distinguished Scientist), and Syntex Chemicals, Inc (Senior Research Chemist). Have worked in the areas of API manufacturing, process development, and process research. Published 20 peer- reviewed articles and six patents. Awarded a Six Sigma Black Belt in 2009; the South East Regional ACS Innovator of the Year (2011); awarded the Boehringer Ingelheim Chemicals, Inc. Team Award (2006); Syntex Chemicals Inc. R & D Award (1990).

    Jason Hamm

    Director - Chemical Development Operations, Bristol-Myers Squibb
    Jason Hamm

    Dr. Jason Hamm is a Director in the Pharmaceutical Development - API Operations group at Bristol-Myers Squibb in New Brunswick, New Jersey. Jason currently is Head of the API Pilot Plants which is responsible for the manufacturing of small molecule drug substances intended for clinical supplies and for the collection of process knowledge to support preclinical, clinical, and commercial manufacture. He manages the small molecule drug substance supply for early and late phase API development to meet both non-clinical and clinical demands. Jason has extensive experience in the CMC development of small molecules through his various roles within Chemical Development and his involvement with technical transfer to internal and external commercial manufacturing sites.
    Jason began his career at Bristol-Myers Squibb in Process Research & Development in New Brunswick in 1998 following the completion of a B.S. in Chemical Engineering at the New Jersey Institute of Technology. He earned his doctorate in Chemical Engineering from Carnegie Mellon University in 2006 while on a BMS Doctoral Fellowship.

    Jhon Escobar

    Operations / Supply Chain Manager, Teva API
    Jhon  Escobar

    Jhon Escobar has highly successful management experience in supply chain and operations. Born in Colombia, living in Mexico since 12 years ago he is capable to plan and develop strategies for operational and budgetary efficiency, proficient in negotiation and conflict resolution.
    Relevant qualifications include a MBA and Industrial Engineer degree with pretty nice recognition a national/international levels in Mexico. With proven leadership skills in the successful management of multidisciplinary work teams, he is a teacher in a local university for Industrial Engineer as a hobby.
    Also of note is the most recent position as Operations Manager for Teva Pharmaceuticals in the API division, on top of the above role, a solid supply chain career in the same organization during the last 7 years.

    Michael Groaning

    Director, Strategic Development, Endocyte
    Michael Groaning

    Michael Groaning (BA, MS, PhD) was trained as a synthetic organic chemist receiving his masters degree working on organometallic catalysis before studying chiral auxiliaries under the tutelage of the late A.I. Meyers at Colorado State University for his doctorate. From there he moved to the ETH-Zurich for his post-doctoral research to work on the total synthesis of Axinellamines in the Erick Carreira labs. His professional career started at F. Hoffman – La Roche in Basel, Switzerland in the Lead Generation department before moving back to Boulder, CO where he started working on highly active APIs in process research. One of his last projects at Roche involved the implementation of HPAPI containment systems in the pilot plant to produce 40-50kg of an HPAPI. He then moved on to Endocyte where his first task was the total synthesis of the highly active natural product Tubulysin B. He transitioned to CMC Regulatory and championed the CMC sections of the European Marketing Authorization Application for vintafolide, a Small Molecule Drug Conjugate with a Vinblastine derivative as its warhead. He now manages Endocyte’s prostate cancer program as Director of Strategic Development.

    Richard Denk

    Head Sales Containment, SKAN AG
    Richard Denk

    Richard Denk is working at the company SKAN AG, headquartered in Allschwil in the position Head Sales Containment. Mr Denk founded 8 years ago the expert Containment group of the ISPE D / A / CH. The Containment Group published the Containment Manual Mr Denk was responsible for in September 2015. Mr Denk has spent nearly 20 years with the subject production of highly active / highly hazardous substances and has developed the containment pyramid.

    Robert Sussman

    Principal Toxicologist and Managing Principal, Eastern Operations, SafeBridge Consultants LLC
    Robert Sussman

    Bob is currently the Managing Principal of SafeBridge Consultants’ Eastern Operations. He has 25 years of experience in the pharmaceutical industry where he has worked in various capacities in corporate occupational toxicology groups for Warner-Lambert and Pfizer, including Senior Director. Bob has an undergraduate degree in Bioenvironmental Engineering from Brown University and a Ph.D. in Environmental Health Science from NYU. He is a Diplomate of the American Board of Toxicology, a past member and chair of the AIHA’s WEEL Committee, and a founding member of the Occupational Toxicology Roundtable. He also has an adjunct appointment at the NYU Medical Center.

    Stefano Butti

    Head of Sales Group, F.P.S. Food and Pharma Systems Srl
    Stefano Butti

    Stefano Butti has studied Mechanical Engineering at university of Milan and graduated in 2000. ISPE member since 2002 he participated as speaker to different congress and seminar on Containment and Micronisation topic both for HPAPI and Sterile application as well as published different articles on technical newspaper.
    He worked as project and process manager in the Chemical and Pharmaceutical business following Containment and Micronisation system installation worldwide. He also took direct role in the definition of containment system upgrade and optimisation for the handling of products with OEL down to ng level with successful results. Also few projects where combination of sterile and toxic compound handling were successfully coordinated during the nearly 15 years spent in this business.
    He joined FPS company in 2008 starting as Technical Sales Manager and he is now head of the Sales group for the company Containment and Micronisation system provided worldwide.

    Sponsors and Exhibitors

    Official Publication

    Supporters

    Workshops

    Risk assessment in HPAPIs (HAZOP)
    Workshop

    Risk assessment in HPAPIs (HAZOP)

    Copthorne Tara Hotel
    24th May 2017
    London, United Kingdom

    VENUE

    Copthorne Tara Hotel

    Scarsdale Place, Kensington, London, United Kingdom

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

     

    HOTEL BOOKING FORM

    Interview with Stefano Butti, Head of Group Sales, F.P.S Food and Pharma Systems

    Download

    Interview with Sean Codling, Managing Director, CTS Europe Limited

    Download

    Containmet of Highly Potent APIs Masterclass Brochure

    Download

    Interview with Aurore Perzyna Head, Production Plant Oril Industrie (Servier)

    Download

    Interview with Shay Carmi, Former OPEX QC Workstream Leader Teva Tech Site, Teva API

    Download

    Interview with Gwydion Churchill, Associate Director of Chemistry, Antibiotics Business Unit, AstraZeneca

    Download

    Interview with Ildiko Ziegler, Distinguished Validation Expert, Gedeon Richter

    Download

    Interview with Robert G. Sussman, Managing Director, Safebridge Consultants

    Download

    Sponsors and Exhibitors


    Asymchem Limited

    Sponsors and Exhibitors
    http://www.asymchem.com/en/

    Asymchem is a USFDA inspected API and HPAPI contract manufacturer focused on developing practical and sustainable chemistry processes for late phase to commercial projects. With six plants across China and strong expertise in continuous flow, biocatalysis, ADC and HPAPI manufacturing and development, Asymchem are the perfect partner for even the most challenging API projects.


    CTS Europe Limited

    Sponsors and Exhibitors
    http://www.containment-technology.co.uk/

    CTS design and manufacture laboratory containment systems for the Pharmaceutical Industry worldwide. Our expertise is in providing containment solutions for potent powders. We have a great deal of experience with many different laboratory applications requiring effective containment. We pride ourselves in being able to design around equipment and processes, allowing analysts to work effectively and safely. Our range includes: Weighing Enclosures, Instrument Enclosures, Glove Boxes, Isolators, Climatic Controlled Enclosures. We are also able to provide on-site Contamination Awareness Training for Laboratory Analysts new to handling potent powders.


    FPS Food and Pharma Systems

    Sponsors and Exhibitors
    http://www.foodpharmasystems.com/en

    We are specialized in fine size reduction equipment and containment systems for many industrial applications. Our micronization technology considers both fluid jet mills and mechanical pin mills to assure the widest fine grinding capabilities. FPS process experts are available to define the more suitable configuration for your fine grinding needs. Containment is a general approach for FPS, allowing us to propose solutions starting from clean rooms up to isolators for sterile or HPAPI manufacturing needs.


    Heraeus

    Sponsors and Exhibitors
    http://www.heraeus-chemicals.com/

    Heraeus’ Business line Pharmaceuticals is the specialist in cytotoxic agents for nearly 30 years. We hold globally a leading position in supply of precious metals based API as well as generic cytotoxic agents Heraeus comprehensive custom services is focused on the synthesis of highly potent compounds (precious metal compounds and small molecules) under high containment conditions and full GMP. In the field of Antibody-Drug-Conjugates our strengths is in payloads. For more details please visit our website www.heraeus-chemicals.com


    Minakem High Potent

    Sponsors and Exhibitors
    http://minakem.be

    More than 40 years’ experience in Highly Potent compounds. High containment systems down to OEB class 5, OEL < 0.1µg / m3 / shift. FDA, GMP and EHS full compliance. Broad range of chemical expertise both on site and in the MINAFIN worldwide network of Fine Chemicals R&D laboratories and plants.


    SafeBridge Consultants, Inc.

    Sponsors and Exhibitors
    http://www.safebridge.com/

    SafeBridge Consultants, Inc. is the premier resource for high level safety, health and environmental support to the pharmaceutical and biotechnology industries. We provide services in occupational and environmental toxicology, risk assessment, product safety, industrial hygiene and analytical chemistry to clients worldwide from offices in California, New York and Liverpool, UK.

    Media Partners


    International Journal of Behavioural and Healthcare Research

    Official Publication
    http://www.inderscience.com/ijbhr

    IJBHR addresses a broad range of original experimental and theoretical papers that deal with behavioural and healthcare concerns. It welcomes high-quality papers from scientists in academic and non-academic organisations as well as business and government worldwide. IJBHR is sponsored by the Business and Economics Society International and the Frontiers in Immunology Research Network.


    International Journal of Computational Biology and Drug Design

    Official Publication
    http://www.inderscience.com/ijcbdd

    IJCBDD, an International Society of Intelligent Biological Medicine official journal, bridges the gap between two very important, complementary disciplines, computational biology and drug design. Through advances in high-throughput genome sequencing and digital imaging technologies, biocomputing, drug design and medical research have unfolded new, predictive sciences such as genomics, proteomics, lipidomics, metabolomics, cytomics and pharmaconomics. These promote new computational, statistical and biomedical approaches to drug design/development, besides unleashing the potential of significantly more accurate, effective personalised diagnosis, therapeutics and patient care.


    International Journal of Cognitive Biometrics

    Official Publication
    http://www.inderscience.com/ijcb

    Cognitive biometrics acquires information from users through collection of one or more biosignals. This relies on the presentation of one or more external or imagined stimuli. The subsequent response(s) are acquired and used for verification and authentication. IJCB addresses all aspects of cognitive biometrics, which aims to extract a unique signature from the user based on the cognitive, affective and conative state of the individual, either alone or more typically in various multi-modal combinations involving conventional and soft biometrics.


    Int. J. of Immunological Studies

    Official Publication
    http://www.inderscience.com/ijis

    IJIS publishes a broad range of papers on all aspects of immunology from scientists in academic and non-academic organisations as well as business and government worldwide. IJIS is the flagship journal of the Frontiers in Immunology Research Network.


    International Journal of Medical Engineering and Informatics

    Official Publication
    http://www.inderscience.com/ijmei

    IJMEI promotes an understanding of the structural/functional aspects of disease mechanisms and the application of technology towards the treatment/management of such diseases. It seeks to promote interdisciplinary collaboration between those interested in the theoretical and clinical aspects of medicine and to foster the application of computers and mathematics to problems arising from medical sciences. IJMEI includes authoritative review papers, the reporting of original research, and evaluation reports of new/existing techniques and devices. Each issue also contains a comprehensive information service.

    Media Partners


    Labsave

    Supporters
    http://www.labsave.com

    Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/


    Pharmacircle

    Supporters
    http://www.pharmacircle.com

    PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


    International Pharmaceutical Industry

    Supporters
    http://www.ipimediaworld.com

    IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. IPI provides a proven supportive means of communication to the Pharmaceutical, Bio Pharmaceutical, Nutraceutical and Medical Devices industry, incorporating the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies.


    Drug Target Review

    Supporters
    http://www.drugtargetreview.com

    Drug Target Review’s quarterly magazine, website and annual events program provides high quality content with peer-written articles that are submitted exclusively by the world’s most respected scientists in their field. This attracts a committed base of readers, users and delegates made up of senior decision-makers from the life science and drug discovery industries at the top pharmaceutical companies, as well as academics and scientists from the top research institutes across the globe.


    Pharmiweb

    Supporters
    http://www.pharmiweb.com

    Established in October 2003, PharmiWeb Solutions is an energetic, innovative provider of web-based solutions for the pharmaceutical sector, with customers such as AstraZeneca, Roche, Servier Laboratories, and Merck With solutions in three key areas: Online Publishing, e-Business and Mobile Computing, we deliver connectivity – between people and applications – unlocking islands of data and knowledge. We own some of the sector’s most innovative Online Publications: PharmiWeb.com, HospitalPharma.com and Detail-Direct.com. We are actively developing solutions for Mobile Computing platforms. For example, our PharmiTabTM e-pharmacy solution runs real-time patient data and prescribing transactions in a busy hospital environment, on a TabletPC, wireless client/server platform. e-Business solutions range from e-Detailing, to Online Market Research, all designed to increase reach, increase sales, and to reduce administration and costs.


    GBI

    Supporters
    http://www.gbihealth.com/

    GBI is an information, applications, and services company focused on the healthcare industry. Leveraging data from across the healthcare value chain, GBI creates web and mobile applications that enable individuals and organizations to make better decisions and communicate more effectively.


    Gate2Biotech

    Supporters
    http://www.gate2biotech.com

    Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


    Pharmavision

    Supporters
    http://www.pharmavision.co.uk

    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.


    Inderscience Publishers

    Supporters
    http://www.inderscience.com

    Inderscience is a dynamic, leading, independent journal publisher. The company disseminates the latest research across the broad fields of science, engineering and technology; management, public and business administration; environment, ecological economics and sustainable development; computing, ICT and internet/web services, and related areas. Inderscience offers over 35 years' experience in publishing and has succeeded in building a substantial collection approaching 400 high-quality peer-reviewed international research journals in both online and print formats. We offer a variety of ways to keep up-to-date with the latest published leading-edge research while our online collection represents a fully-searchable digital archive of around 60,000 articles.


    Drug Discovery Today

    Supporters
    http://www.drugdiscoverytoday.com/

    Drug Discovery Today is one of the most cited review journals in the field of drug discovery, with an impact factor of 6.422.
    Drug Discovery Today will benefit your research by helping to keep you up-to-date with all of the fast-moving and emerging topics in drug discovery. Each issue is packed full of the latest research news, peer-reviewed articles and comment and opinion from leading research scientists.


    Bioscreening

    Supporters
    http://www.bioscreening.com



    RareBase

    Supporters
    http://www.rarebase.co.uk

    The RareBase Networking Portal links people and companies throughout the world with an interest in rare and paediatric diseases.


    CanBiotech

    Supporters
    http://www.canbiotech.com

    CanBiotech - A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Outsourcing Services Showcase; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the BioMedical Outsourcing Report and the Bio Outsourcing Asia© Publication.


    AntibodyChain

    Supporters
    http://www.antibodychain.com

    The complete and transparent marketplace for your research antibodies, kits, proteins and small molecules. The sophisticated search engine, with more than 800.000 products, transparency in suppliers, easy comparison, the one stop shop for your research antibodies in combination with interesting news and events plus a CMO exchange makes us a full service partner for you.


    Pharmaceutical Technology

    Supporters
    http://www.pharmaceutical-technology.com

    Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.


    European Biopharmaceutical Review

    Supporters
    http://www.samedanltd.com/magazine/12

    European Biopharmaceutical Review (EBR) is a magazine dedicated to the biopharmaceutical and biotech industries. Each quarterly edition features articles from key opinion leaders on research, drug discovery and development, biomanufacturing, outsourcing and more on the science and business of the sectors. EBR also features insightful interviews, reviews and event information to form a strong B2B platform. Read EBR in print, online, or via the Samedan app.


    British Pharmacological Society

    Supporters
    http://www.bps.ac.uk

    The British Pharmacological Society (BPS) is the primary UK learned society concerned with research into drugs and the way they work. Our members work in academia, industry, regulatory agencies and the health services, and many are medically qualified. The Society covers the whole spectrum of pharmacology, including laboratory, clinical, and toxicological aspects. Clinical pharmacology is the medical speciality dedicated to promoting safe and effective use of medicines for patient benefit. Clinical pharmacologists work as consultants in the NHS and many hold prominent positions in UK Universities.


    Farmavita

    Supporters
    http://www.farmavita.net/

    Farmavita Net is professional community and network of pharmaceutical licensing and business development executives, innovators and researchers
    Farmavita.Net is the pharmaceutical licensing, technology transfer and regulatory affairs network. We are managing the marketplace of offers and demand for pharmaceutical Dossiers, know-how and technologies. Members of Farmavita.Net network usually find a number of attractive solutions for business development, alliances, joint ventures, co-development and co-marketing of pharmaceutical products. Farmavita.Net is not just a pure Internet portal. We manage a number of regional associates. We are connecting the dynamic network of few hundreds members / pharmaceutical companies interested in license-in and license-out opportunities.


    Pharmaceutical-Tech

    Supporters
    http://www.pharmaceutical-tech.com

    In the realm of Pharmacy, where innovation is rapid, Pharmaceutical-Tech stands adept at conceptualizing unique ideas relevant to the B2B space. Pharmaceutical-Tech is essentially a B2B online business, technology media platform and global magazine that have under its wraps the largest global database of Pharmacy buyers and suppliers. Pharmaceutical-Tech.com covers in-depth trends that shape industry dynamics and metamorphose global economics. With services like search engine optimization, global magazine, social media marketing, product video showcase, e-mail marketing, e-newsletter sponsorship, banner advertising, event marketing and micro-website within our platform, www.pharmaceutical-tech.com has created a recognition that spans over a global audience, thereby revolutionizing how businesses transact.


    pharmaphorum

    Supporters
    http://www.pharmaphorum.com

    pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com


    Drug Development Technology

    Supporters
    http://www.drugdevelopment-technology.com

    Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.


    Pharmalicensing

    Supporters
    http://www.pharmalicensing.com

    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing, and its sister service Medical Device Licensing (www.medicaldevicelicensingcom) are actively utilized by over 200,000 industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.


    Swiss Biotech Association

    Supporters
    http://www.swissbiotech.org/

    The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.


    PMR

    Supporters
    http://www.pmrcorporate.com

    PMR (www.pmrcorporate.com) is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern European countries as well as other emerging markets. PMR's key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research ). Being present on the market since 1995, offering high international standards in projects and publications, as well as providing one of the most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.


    Bentham Science

    Supporters
    http://www.benthamscience.com/

    Bentham Science Publishers is a major STM journal publisher of 116 titles and 200 plus open access journals and print/online book series (Bentham eBooks). Bentham Science answers the information needs of the pharmaceutical and biomedical research community. Leading journals include Current Drug Metabolism (Impact Factor 5.113) and Current Medicinal Chemistry (Impact Factor 4.859): FREE online journals and information: www.benthamscience.com


    Biosave

    Supporters
    http://www.Biosave.com

    Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.


    ASD MEDIA

    Supporters
    http://www.asd-network.com

    Professionals in the Aerospace & Defence market use the ASD Media internet platforms to:
    • Be informed on the latest market developments; www.asd-network.com
    • Find the latest business news; www.asd-network.com
    • Find the upcoming events; www.asd-network.com
    • Find companies and organizations; www.asdsource.com
    • Distribute news globally. www.asdwire.com
    The ASD Media platforms are well known and used intensively, your company is able to benefit from these large numbers of users. Be informed with ASD-Network; Create exposure for your company with ASDSource, distribute your news with ASDWire or advertise with us, build your brand and increase traffic to your company’s website.

    For more detailed information please contact with: ASD MEDIA
    Stefan.koopman@asdmedia.nl


    Absave

    Supporters
    http://www.absave.com

    Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!


    Labiotech.eu

    Supporters
    http://labiotech.eu

    Labiotech.eu is the leading digital media covering the European Biotech industry. It is used by over 55000 people monthly to keep a watch on the business and innovations of biotechnologies.


    BioPharm Insight

    Supporters
    http://www.biopharminsight.com

    BioPharm Insight is your definitive guide to the global life sciences community. Subscribers take action on forward-looking intelligence uncovered by an independent team of investigative journalists, and make strategic business decisions using the most comprehensive and powerful real-time database of market analytics and key contacts. Featuring an intuitive online interface and exclusive Active IntelT relational content technology, BioPharm Insight provides an unrivaled capability to segment and analyze the industry with detailed and searchable profiles.


    Select Science

    Supporters
    http://www.selectscience.net/

    SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover impartial, expert opinion and trusted reviews about latest laboratory equipment and techniques; plus videos, application notes and science news from around the world. Become a member for free today.


    Copybook - Pharmaceutical

    Supporters
    http://www.copybook.com/pharmaceutical

    Copybook is a global business network with many pharmaceutical events, exhibitions and seminars. We encourage business-to-business transactions and work tirelessly to gain our customers new business contracts worldwide. You can add events, companies and associations for free. When you are a member, you can add your company to the events listed in order to encourage other visitors to arrange meetings and appointments at those events to facilitate new business contracts. Want to see how we can increase your business network and transactions? SIGN UP FOR FREE today! Copybook – Your Global Business Network


    Biocompare

    Supporters
    http://www.biocompare.com

    Biocompare.com is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information.


    Technology Networks

    Supporters
    http://www.technologynetworks.com

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


    CLocate

    Supporters
    http://www.clocate.com

    Clocate.com is a leading international directory for worldwide conferences and exhibitions. Clocate.com is equipped with a unique and comprehensive search that helps you find easily any event in any category or location. Each event includes detailed information, like, description, dates, location, map, prices, link to the official event's website and more...


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    BioChem Adda

    Supporters
    https://www.biochemadda.com/

    BioChem Adda is a Not-just-for-Profit organization which aims to bring out the most reliable and transparent information about everything related to jobs, careers, education, news, articles, and events from the field of BioSciences and Chemistry!


    Samedan

    Supporters
    http://www.samedanltd.com/magazine/13.

    International Clinical Trials (ICT) is a quarterly magazine edited by Dr Graham Hughes, and written by specialists at the forefront of clinical research. ICT’s coverage of operational developments ranges from adaptive designs in early phase trials through to post marketing research. ICT’s targeted readership consists of key decision makers across the pharmaceutical and biotech industries, along with contract partners and consultants. The magazine is distributed to pharmaceutical professionals in Europe and North America, and is accessed globally online. Read the latest issues, explore the ICT archive and subscribe at www.samedanltd.com/magazine/13.

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Copthorne Tara Hotel

    Scarsdale Place
    Kensington
    London W8 5SR
    United Kingdom

    Copthorne Tara Hotel

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

     

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.